of over 300000000 that initial round that the base is secure with gilliatt from the u.s. government's perspective really takes into account about half a 1000000 treatment courses within the u.s. hospitals right. but like i mentioned earlier there are plans in place to try to scale up production by having agreements with several generic manufacturers in india i know for a fact in egypt in pakistan tell out them to produce from best of the air especially for a lot of these more lower income a lower mid middle income type of countries that need it now on the other hand you know some of the countries not on that list brazil china japan mexico some other european nations i know for a fact many of the patients that were in your early clinical trials came from the u.k. so i know that there's kind of been a you know an outcry in some of the european nations which have said look we've been involved in the clinical trials early on and now we're not going to have access to it and that can be disappointing but i think more and more than anything to me this could be potentially a sign

of gilliatt daniel o'dea justify this discussed during practice he said there underpricing ram decimeters in normal circumstances we would price medicine according to the value it provides earlier hospital discharge would result in a hospital savings of approximately $12000.00 per patient while makes a lot of sense. oh wait no that's stupid the value it provides to that would mean if a doctor save someone's life with heart surgery then that guy owed the doctor the entire worth of the rest of his life millions of dollars and maybe should just be the surgeon's butler. my bill says butler well kids see daddy owes his life to another family now good luck on childhood remember to wipe your front to back and never sleep with your interns never turns out well the value it provides so for a dude taking by agra who can now get it up you owe the makers of viagogo what sex with their wives or do you just show them 300 orgasms bend over pfizer wrap i need to give you the equivalent value your bother pills have given them a or do you owe them the child you were able to produce with the pills dear cial

now let's turn to the pandemic drug manufacturer gilliatt sciences has announced the cost of does appear in experimental treatment for cove in $19.00 but the national institute of allergy and infectious diseases says can reduce coronavirus hospitalization by 4 days now the price tag for the recommended $5.00 day course of severe is a whopping $3120.00 patients with private health insurance will pay out of pocket expenses for the drug while the government will reportedly reimburse hospitals for treatments administered to uninsured patients due to privileges in the care is act as long as the funding is still available and patients meet certain criteria regulatory filings related to the drug reveal that gilliatt received over $70000000.00 from taxpayers to develop severe so far the drug has not demonstrated is statistically significant impact on survival rates still it's the only treatment authorized by the f.d.a. to treat hospitalized $1000.00 patients the trump administration has now secured a contract with for $500000.00 courses of the medicine nearly all of the company's supply meanwhil

but there's another catch to gilliatt price gouging faced man again they didn't create rem doesn't fear we did human meat it gillie gaddis received at least $70500000.00 from taxpayers according to the advocacy group public citizen which reviewed regulatory filings and the national institutes of health ran the trial that led to rim does a variance or emergency use authorization and public funding is supporting clinical trials around the world today you and i paid for the creation and research behind rem doesn't mean there is absolutely no reason we should fill the pockets of gimli had incredibly rich c.e.o. and its board of ass. and i bet you knew this next part was coming but nearly all other developed countries limit how much pharmaceutical companies can charge for prescription meds the us doesn't operate like that we allow drug companies to charge as much as they please which is wise to cite just one example the cost of insulin has nearly tripled in recent years for people with diabetes. other countries don't destroy people's lives if they have the nerve to want to survive a life thr

vote actually probably started by the end of july and we've seen that before look at companies like gilliatt for example or more daryn over there also was such a big hope at the beginning and then it turned out that it's not it's not going to happen that quickly that we will get to treatment or even of a c. now even though the pandemic clearly overshadows pretty much everything these days they're all all there is all the new certainly for investors and test made headlines that tell us more. it's been amazing right in the past year the stock of tesla basically almost tripled and now chester actually is the world's most valuable car company on the planet even surpassing. toyota that's been their leader in the past couple of years and if you look at the valuation of tesla would have $200000000000.00 it's worth twice as much as this ridiculous car companies forte if you're a chrysler and general motors but clearly wall street is not seeing tesla as a car company it sees tesla as a technology company also being involved in better reason and all electronic mobility or lecturing mobility but it's r

based gilliatt one of the most profitable pharmaceutical companies worldwide sales reaching 22000000000 dollars last year the u.s. has already bought up most of the drugs production capacity as negotiations with e.u. supplies are underway you officials say they could give german and all the e.u. drug makers a license to produce the drug even without to get approval for an appropriate feat . so how significant is the use approval of via our financial markets correspondent chelsea delaney has more. disappear has been officially approved by the e.u. but whether there will be any of the drug available to your members is a big question right now the u.s. has bought about 90 percent of the available supply there september so this is obviously stoking a lot of concern here in europe about what would happen if we saw a 2nd wave of infections here as well at the same time this is reigniting all these fears about the very nationalistic and 1st approaches of some countries to coronavirus vaccines and treatments the 1st face to face brics is talk since the coronavirus pandemic began have ended a da

that has faced criticism for agreeing to sell the vast majority of its output to the united states gilliatt told g.w. that its face difficulty meeting demand and that it's planning to increase the production of ramdass of beer from the current 190000 batches per month to $2000000.00. future supplies the company says will be allocated on the basis of the number of new infections in a country. european policy makers have also been threatening to impose compulsory licensing on ramdass of fear this would allow other manufacturers to produce the drug under world trade organization rules such a move would be possible in the case of a national emergency and we asked european parliamentarian peter lees why the e.u. might bypass the patent when the company insists it will deliver the drug. yes it will do it well but i'm not sure if it is not you know for the moment in the united in the european union the figures are quite low but we don't know what's going to happen and work wise we have really a lot of hot spots where the outbreaks are huge and that's why i'm not sure if what this is going to deliv

welcome to the program and thank you so much for joining us why are you taking such a big step and gilliatt insists that they will deliver the job. yeah they will do it well but i'm not sure if it is not you know for the moment in the united in the european union the figures are quite you know but we don't know what's going to happen and work while we have really a lot of hospitals where the outbreaks are huge and that's why i'm not sure if what this is going to deliver will be enough and we just adopted the resolution in the european parliament where we say that we call on cooperation and die in the uk so i would guess preferred to be gods themselves words cooperate with companies . outside of us to produce the drug but if not the international law for cease relicensing so it's not something that invents it is for. you know the most is into a food and i think we are in an emergency situation is is this a taste of what we might see when a coronavirus vaccine becomes available. unfortunately yes. we we will probably not have not enough doses of vaccine. when the vaccine is approved so we are

hospital it's priced room does appear fairly senator bernie sanders claim that run does appear cost gilliatt $10.00 a vial to manufacture and as you heard taxpayers are paid $70000000.00 towards the cost of development of that's crucial as many americans don't have or have lost their health insurance and can't afford to pay for the drug the problem is getting out has made the same claim before it bought the start up behind a ready ready to market hepatitis c. drug for $11000000000.00 and began to market the drug for $84000.00 allowing its almost recoup the cost of acquisition in the 1st year according to bloomberg so how much does big pharma spend on developing drugs will on average $2600000000.00 according to tufts university but advocacy group public citizen believes the cost is close as a one point $4000000000.00 as governments spend billions securing supplies of potential covert 19 vaccines pfizer is charging roughly $20.00 for a dose which the company claims is 30 percent less than what other drug makers charge for seasonal flu jab. and because it isn't receiving government money for re

that has faced criticism for agreeing to sell the vast majority of its output to the united states gilliatt told the w that it's face difficulty meeting demand and that it's planning to increase the production of ramdass of beer from the current 190000 batches per month to $2000000.00. future supplies the company says will be allocated on the basis of the number of new infections in a country. european policy makers have also been threatening to impose compulsory licensing on ramdass severe this would allow other manufacturers to produce the drug under world trade organization rules such a move would be possible in the case of a national emergency. this is news here's a reminder of all top stories this turkish president out of office formerly the iconic high as the fia into a mosque despite international objections to earlier ruled earlier today and the knowledge and 934 decree that have turned. into the music. is marking 25 years since the genocide more than a 1000 people mostly men and boys were killed by serbian forces during the massacre in july 9090. you're watching the news i'll have

of gilliatt daniel o'dea justify this discussed during practice he said there underpricing ram decimeters in normal circumstances we would price a medicine according to the value it provides earlier hospital discharge would result in a hospital savings of approximately $12000.00 per patient all makes a lot of sense. oh wait no that's stupid the value it provides to that would mean if a doctor save someone's life with heart surgery then that guy over the doctor the entire worth of the rest of his life millions of dollars and maybe should just be the surgeon's butler. my bill says butler well kids see daddy owes his life to another family now good luck on childhood remember to wipe your front to back and never sleep with your new.

of gilliatt daniel o'dea justify this discussed during practice he said there on.

market namely the fed amazon and this hope for a vaccine so today on friday we got the report from gilliatt saying that the vaccine could be ready by as soon as december so this reopening trade is fading and the rotation of high beta stock is also slowing down and in the near term it's going to be difficult to find anything compelling so really the only thing that's going to be leading the market right now is going to be tech names as well as the fed. chrissy our thanks for your expert analysis. global markets are mixed this week as they could tell you to react to a resurgence of coronavirus cases worldwide let's start in russia where the mo x. is down on the week the ruble fell on friday after some gains throughout the week due to a decrease in oil prices and concern over a renewed lockdown now something to keep an eye on is the nation central bank data for balance of payments for the 2nd quarter of this year amid the height of the pandemic let's move to asian markets where the shanghai composite it's in the green for the week with gains early on in the week due to china's june inflation d

vaccines and treatments for coping 1000 have exponential stock growth but this includes the likes of gilliatt novio and novak's just to name a few on monday u.k. based biotech firm synergy and its stock spiked more than 500 percent after reporting their experimental drug was mostly successful in preventing serious symptoms related to cope with 19 in trials the company's s n g 001 drug reduce the odds of a patient developing severe symptoms including the need for a ventilator by 79 percent compared to patients receiving a placebo now adding that those who received the drug were 2 to 3 times more likely to recover from cope with 19 now the trial involved 220 subjects in the united kingdom they say more analysis from the trial results will be disclosed in the coming week and with all that in mind let's go ahead and take a global look at the spread of the virus with r.t. correspondent so i where are we worldwide sobran over a 24 hour period over the weekend the world nearly $260000.00 and new cases a new record which brings the total of global number to over $14.00 d 6000000 now 30 percent of the

has purchased 90 percent of the world's supply from does appear that's the deal struck between gilliatt sciences to supply more than 500000 treatment courses to the u.s. until september does appear if you remember is the only drug so far proven as treatment for coke at 19 and reportedly speeds up recovery time for infected people . and right here in the nation's capital the senate reached a last minute deal to extend the paycheck protection program to early august just hours before the program was due to expire the federal loan program to help small business is also extended for an additional 5 weeks with more than $130000000000.00 in loan money left on spent the legislation now heads to the house which will also be adjourning later this week. check this out if you are looking for stress relief maybe you could do the trick like in bangladesh more than $700.00 police officers are taking part in yoga as you can see there the officers are social distancing they're wearing masks they're stretching and even running in place at times they've been on the front line of enforcing that country's

purchased nearly all stock of the corona virus trigram does appear this is a drug made by gilliatt right that provides useful treatment to the sickest kogan 1000 patients is this the u.s. being a protectionist what do we think. well. the answer to whatever issues come out of this cove in 1000 situation will have to do less with red as a fear which by the way has really been a very effective drug and for people who are hospitalized and in the secondary or tertiary stage of this disease it is very effective in other words not for somebody who just got it bright somebody who's had to be hospitalized with it it's very expensive so they're going to do very well with it the real answer here is going to be from johnson and johnson from sanofi. a french firm mcgurn a ad from astra zeneca if you've got a couple of extra bucks and you want to put it in the stock market look at those companies because those are the companies that right now have the edge when it comes to the vaccine right and one of them the french company sanofi already has tested starting in april something like 300 people in othe